“Sleep And Neurochemical Modulation By Cannabidiolic Acid Methyl Ester In Rats”. Brain Research Bulletin, 155, Pp. 166-173. doi:10.1016/j.brainresbull.2019.12.006. Publisher's Version
. 2020. Raphael Mechoulam
“Acute Naloxone-Precipitated Morphine Withdrawal Elicits Nausea-Like Somatic Behaviors In Rats In A Manner Suppressed By N-Oleoylglycine”. Psychopharmacology, 237, 2, Pp. 375-384. doi:10.1007/s00213-019-05373-2. Publisher's Version
. 2020. “Oleoyl Alanine (Hu595): A Stable Monomethylated Oleoyl Glycine Interferes With Acute Naloxone Precipitated Morphine Withdrawal In Male Rats”. Psychopharmacology, 237, 9, Pp. 2753-2765. doi:10.1007/s00213-020-05570-4. Publisher's Version
. 2020. “Protective Effects Of N-Oleoylglycine In A Mouse Model Of Mild Traumatic Brain Injury”. Acs Chemical Neuroscience, 11, 8, Pp. 1117-1128. doi:10.1021/acschemneuro.9b00633. Publisher's Version
. 2020. “Altered Dopamine D3 Receptor Gene Expression In Mam Model Of Schizophrenia Is Reversed By Peripubertal Cannabidiol Treatment”. Biochemical Pharmacology, 177. doi:10.1016/j.bcp.2020.114004. Publisher's Version
. 2020. “Beyond Thc And Endocannabinoids”. Annual Review Of Pharmacology And Toxicology, 60, Pp. 637-659. doi:10.1146/annurev-pharmtox-010818-021441. Publisher's Version
. 2020. “An Evaluation Of The Anti-Hyperalgesic Effects Of Cannabidiolic Acid-Methyl Ester In A Preclinical Model Of Peripheral Neuropathic Pain”. British Journal Of Pharmacology, 177, 12, Pp. 2712-2725. doi:10.1111/bph.14997. Publisher's Version
. 2020. “Cannabidiol Partially Blocks The Excessive Sleepiness In Hypocretin-Deficient Rats: Preliminary Data”. Cns And Neurological Disorders - Drug Targets, 18, 9, Pp. 705-712. doi:10.2174/1871527318666191021143300. Publisher's Version
. 2019. “N-Oleoyl-Glycine Reduces Nicotine Reward And Withdrawal In Mice”. Neuropharmacology, 148, Pp. 320-331. doi:10.1016/j.neuropharm.2018.03.020. Publisher's Version
. 2019. “Effects Of Cannabidiol In Males And Females In Two Different Rat Models Of Depression”. Physiology And Behavior, 201, Pp. 59-63. doi:10.1016/j.physbeh.2018.12.019. Publisher's Version
. 2019. “Cannabidiol Presents An Inverted U-Shaped Dose-Response Curve In A Simulated Public Speaking Test”. Revista Brasileira De Psiquiatria, 41, 1, Pp. 9-14. doi:10.1590/1516-4446-2017-0015. Publisher's Version
. 2019. “Oleoyl Glycine: Interference With The Aversive Effects Of Acute Naloxone-Precipitated Mwd, But Not Morphine Reward, In Male Sprague–Dawley Rats”. Psychopharmacology, 236, 9, Pp. 2623-2633. doi:10.1007/s00213-019-05237-9. Publisher's Version
. 2019. “Peripubertal Cannabidiol Treatment Rescues Behavioral And Neurochemical Abnormalities In The Mam Model Of Schizophrenia”. Neuropharmacology, 146, Pp. 212-221. doi:10.1016/j.neuropharm.2018.11.035. Publisher's Version
. 2019. “Real Life Experience Of Medical Cannabis Treatment In Autism: Analysis Of Safety And Efficacy”. Scientific Reports, 9, 1. doi:10.1038/s41598-018-37570-y. Publisher's Version
. 2019.